Evidence-Based Medicine Guidelines
Certolizumab pegol for rheumatoid arthritis in adults
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Certolizumab Pegol for Rheumatoid Arthritis in Adults." Evidence-Based Medicine Guidelines, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/457299/all/Certolizumab_pegol_for_rheumatoid_arthritis_in_adults.
Certolizumab pegol for rheumatoid arthritis in adults. Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/EBMG/457299/all/Certolizumab_pegol_for_rheumatoid_arthritis_in_adults. Accessed May 19, 2025.
Certolizumab pegol for rheumatoid arthritis in adults. (2025). In Evidence-Based Medicine Guidelines. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/EBMG/457299/all/Certolizumab_pegol_for_rheumatoid_arthritis_in_adults
Certolizumab Pegol for Rheumatoid Arthritis in Adults [Internet]. In: Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. [cited 2025 May 19]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/457299/all/Certolizumab_pegol_for_rheumatoid_arthritis_in_adults.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Certolizumab pegol for rheumatoid arthritis in adults
ID - 457299
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/457299/all/Certolizumab_pegol_for_rheumatoid_arthritis_in_adults
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
